SEC Form D private-offering filing

Immunomet Therapeutics, Inc.

Name: Immunomet Therapeutics, Inc. - new SEC Form D private-offering filing, Houston, TX
Published: 2026-02-05

A new SEC Form D private-offering notice from Houston, TX, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Immunomet Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech in Houston, TX developing oxidative phosphorylation inhibitor drugs for cancer and fibrosis.

Filed 2026-02-05Filed to raise $10,000,000First money in 2026-01-21Raised so far $842,211HQ (as filed) Houston, TXSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified immunomet.com↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.